Plasma-Derived ApoA-1
Findings suggest CSL112 can boost cholesterol efflux capacity in patients with impaired endogenous HDL function. Encouragingly, several studies have documented its ability to reduce atherosclerotic plaque volume.
Stopping Alzheimer’s with a Preventative Vaccine?
Despite the many vaccine candidates undergoing clinical trials, experts doubt an effective vaccine for Alzheimer’s disease is on the horizon.
Researchers Discover New, Rare Autoimmune Disease
A previously unknown autoimmune muscle disease involving sudden onset of debilitating muscle pain and weakness has been identified by researchers at Washington University School of Medicine in St. Louis, Mo.
Scientists Uncover Breakthrough in Development of Universal Flu Vaccine
Researchers at the University of Melbourne have discovered immune cells that can fight all different kinds of the influenza (flu) virus.
Excellent Response to Therapeutic Plasma Exchange in Myasthenia Gravis Patients with or Without Autoantibodies
A study out of the University of Texas Southwestern Medical Center found a 96 percent response rate to treatment with therapeutic plasma exchange (PLEX) in a series of 58 consecutive myasthenia gravis (MG) patients, with no significant difference in response between those with or without autoantibodies.
Serum Albumin a Strong Predictor of Mortality in Sepsis: Two New Studies
Two studies suggest low serum albumin levels in patients with sepsis is associated with mortality.
Human Vaccines Project Launches Study of How the Immune System Responds to the Flu
The Human Vaccine Project aims to understand how the human immune system can develop longer-lasting protection against influenza.
Study Says Glaucoma May Be an Autoimmune Disease
A study conducted by MIT and the Massachusetts Eye and Ear has found glaucoma may be an autoimmune disorder.
Neonatal Fc Receptor Antagonist Efgartigimod Sustainably Reduces Circulating IgG Level in Humans
Investigators from the Belgian biotechnology company argenx and U.S. collaborators conducted a PhaseI clinical study to assess a novel modified antibody Fc fragment (efgartigimod) that reduces the circulating IgG level by blocking neonatal Fc receptor-mediated IgG recycling.
Study Shows Newborns’ Immune Systems Ramp Up After Birth
A new study shows newborns’ immune systems ramp up immediately after birth.
